*Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to Sugar.IQ insights that can inform users of clinically relevant glucose patterns.
**The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
^Refers to Auto Mode. Some interaction required. Individual results may vary.
† Cohen O, et al. Avoidance of Glucose Excursions by the Guardian™ Connect CGM system – real world Poster presented at Advanced Technologies & Treatments for Diabetes conference; 2018 February 14-18, Vienna, Austria. data.
§ Users from outside of the U.S., using an earlier version of the Guardian™ Connect App. Low episode is defined as ≤70mg/dL in sensor glucose level; high episode as ≥180mg/dL in sensor glucose level. CareLink™ data from January 2, 2017 to January 2, 2018 (n=3,720).
‡ Low episode is defined as ≤70mg/dL in sensor glucose level; high episode as ≥180mg/dL in sensor glucose level.